Intercept Pharmaceuticals Inc (NASDAQ:ICPT)

221.37
Delayed Data
As of Feb 27
 +2.30 / +1.05%
Today’s Change
128.50
Today|||52-Week Range
484.99
+41.90%
Year-to-Date

Today’s Trading

Previous close219.07
Today’s open220.25
Day’s range216.54 - 221.80
Volume401,649
Average volume (3 months)552,971
Market cap$5.0B
Dividend yield--
Data as of 3:59pm ET, 02/27/2015

Growth & Valuation

Earnings growth (last year)+48.91%
Earnings growth (this year)-275.76%
Earnings growth (next 5 years)-6.30%
Revenue growth (last year)-33.71%
P/E ratioNM
Price/Sales759.12
Price/Book52.09

Competitors

 Today’s
change
Today’s
% change
SGENSeattle Genetics Inc-0.18-0.49%
AKRXAkorn Inc+0.34+0.64%
GRFSGrifols SA-0.55-1.65%
RCPTReceptos Inc+0.13+0.10%
Data as of 3:59pm ET, 02/27/2015

Financials

Next reporting dateMarch 2, 2015
EPS forecast (this quarter)-$1.68
Annual revenue (last year)$1.6M
Annual profit (last year)-$67.8M
Net profit margin-4,180.52%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Mark E. Pruzanski
Chief Financial Officer, Secretary &
Treasurer
Barbara Gayle Duncan
Corporate headquarters
New York, New York

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account